Trial · NCT02679170
Results by group326
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 326
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ALK Treatment Sub-study | 0 | 35 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ROS1 Treatment Sub-study | 0 | 11 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ALK Treatment Sub-study | 1 | 43 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ROS1 Treatment Sub-study | 1 | 29 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ALK Treatment Sub-study | 2 | 2 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ROS1 Treatment Sub-study | 2 | 2 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ALK Treatment Sub-study | 3 | 1 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ROS1 Treatment Sub-study | 3 | 0 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ALK Treatment Sub-study | 4 | 0 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ROS1 Treatment Sub-study | 4 | 0 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ALK Treatment Sub-study | 5 | 0 | Participants | |
| Eastern Cooperative Oncology Group (ECOG) Quality of Life Score: ALK Treatment and ROS1 Sub-study Only | ROS1 Treatment Sub-study | 5 | 0 | Participants | |
| Number of Participants Classified According to the Origin of Tumor Sample | ALK Incidence Sub-study | Primary tumor | 409 | Participants | |
| Number of Participants Classified According to the Origin of Tumor Sample | ALK Treatment Sub-study | Primary tumor | 63 | Participants | |
| Number of Participants Classified According to the Origin of Tumor Sample | ROS1 Treatment Sub-study | Primary tumor | 28 | Participants | |
| Number of Participants Classified According to the Origin of Tumor Sample | ALK Incidence Sub-study | Metastases | 150 | Participants | |
| Number of Participants Classified According to the Origin of Tumor Sample | ALK Treatment Sub-study | Metastases | 28 | Participants | |
| Number of Participants Classified According to the Origin of Tumor Sample | ROS1 Treatment Sub-study | Metastases | 22 | Participants | |
| Number of Participants Classified According to Type of Sample Collected for Tumor Analysis | ALK Incidence Sub-study | Biopsy | 466 | Participants | |
| Number of Participants Classified According to Type of Sample Collected for Tumor Analysis | ALK Treatment Sub-study | Biopsy | 75 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02679170/results